
    
      A prospective randomized control trial; 50 women undergoing pregnancy termination in the
      second trimester (14-28 weeks)in each group.

      Following receiving an ethical approval by the local institutional review board (IRB),
      committee, consecutively all women in between 14 weeks to 28 weeks; that have a reason for
      termination of pregnancy like: intrauterine fetal death or medical or genetic indications for
      termination of pregnancy or socioeconomic termination of pregnancy will be offered to take
      part in the study. If eligible according to the inclusion and exclusion criteria, women will
      be asked to sign a consent form.

      All participants will undergo blood exams (CBC, Prothrombin time, Partial thromboplastin time
      , and BLOOD TYPING) and ultrasound exam for Confirmation of diagnosis as routinely indicated
      for missed abortion at our department
    
  